PLASMA Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The PLASMA Act (H.R. 6465) is a health-related bill introduced in the 118th Congress. The bill was referred to the Subcommittee on Health on December 17, 2024, but no official summary or full text is publicly available. The bill did not advance and is currently classified as failed or expired. Due to the lack of detailed information, the specific provisions, goals, or mechanisms of the bill cannot be determined from the available data.
H.R. 6465, the PLASMA Act, is a health policy bill that was introduced but did not progress beyond subcommittee referral and ultimately expired without further action.
- The bill is titled the PLASMA Act and relates to the health policy area.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health on December 17, 2024.
- No official summary or full text is publicly available, and the bill status is failed/expired.
Due to the absence of detailed bill text or summary, it is unclear who specifically would benefit. Potential beneficiaries could include patients, healthcare providers, or organizations involved in plasma-related health issues, but this cannot be confirmed from the available information.
Without access to the bill's text or summary, potential concerns such as implementation challenges, costs, authority delegation, or oversight mechanisms cannot be assessed. The lack of transparency limits evaluation of policy tradeoffs or risks.
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health but did not advance further. The failure or expiration status indicates it did not receive sufficient legislative support or prioritization to move forward.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
Due to the lack of detailed information, indirect effects cannot be reliably identified. Generally, health-related legislation can impact healthcare delivery, funding priorities, and patient outcomes, but specific effects of this bill are unknown.
The absence of publicly available bill text and summary hinders transparency and public accountability. This limits the ability of stakeholders to evaluate the bill's provisions, potential impacts, and alignment with public interests. Improved disclosure of legislative materials is essential for effective government transparency.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.